Annual CFF
$33.17 M
+$25.38 M+325.69%
December 1, 2023
Summary
- As of February 7, 2025, RVPH annual cash flow from financing activities is $33.17 million, with the most recent change of +$25.38 million (+325.69%) on December 1, 2023.
- During the last 3 years, RVPH annual CFF has risen by +$20.35 million (+158.61%).
- RVPH annual CFF is now at all-time high.
Performance
RVPH Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$3.62 M
+$941.40 K+35.12%
September 1, 2024
Summary
- As of February 7, 2025, RVPH quarterly cash flow from financing activities is $3.62 million, with the most recent change of +$941.40 thousand (+35.12%) on September 1, 2024.
- Over the past year, RVPH quarterly CFF has increased by +$3.62 million (+100.00%).
- RVPH quarterly CFF is now -88.50% below its all-time high of $31.50 million, reached on June 30, 2021.
Performance
RVPH Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$33.91 M
+$3.62 M+11.96%
September 1, 2024
Summary
- As of February 7, 2025, RVPH TTM cash flow from financing activities is $33.91 million, with the most recent change of +$3.62 million (+11.96%) on September 1, 2024.
- Over the past year, RVPH TTM CFF has increased by +$27.99 million (+472.84%).
- RVPH TTM CFF is now -22.44% below its all-time high of $43.71 million, reached on June 30, 2021.
Performance
RVPH TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
RVPH Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +325.7% | +100.0% | +472.8% |
| 3 y3 years | +158.6% | -30.5% | +147.6% |
| 5 y5 years | +10000.0% | -30.5% | +147.6% |
RVPH Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +325.7% | -86.7% | -100.0% | at high | >+9999.0% |
| 5 y | 5-year | at high | >+9999.0% | -88.5% | -100.0% | -22.4% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -88.5% | -100.0% | -22.4% | >+9999.0% |
Reviva Pharmaceuticals Holdings Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $3.62 M(+35.1%) | $33.91 M(+12.0%) |
| Jun 2024 | - | $2.68 M(+707.4%) | $30.28 M(-7.7%) |
| Mar 2024 | - | $332.00 K(-98.8%) | $32.82 M(-1.1%) |
| Dec 2023 | $33.17 M(+325.7%) | $27.27 M(>+9900.0%) | $33.17 M(+460.4%) |
| Sep 2023 | - | $0.00(-100.0%) | $5.92 M(-56.8%) |
| Jun 2023 | - | $5.21 M(+658.7%) | $13.69 M(+61.5%) |
| Mar 2023 | - | $687.10 K(+3594.1%) | $8.48 M(+8.8%) |
| Dec 2022 | $7.79 M | $18.60 K(-99.8%) | $7.79 M(-1.0%) |
| Sep 2022 | - | $7.77 M(>+9900.0%) | $7.87 M(+7884.3%) |
| Jun 2022 | - | $0.00(-100.0%) | $98.60 K(-99.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $100.00(-99.9%) | $31.60 M(+0.0%) |
| Dec 2021 | $31.60 M(+146.3%) | $98.50 K(>+9900.0%) | $31.60 M(-26.2%) |
| Sep 2021 | - | $0.00(-100.0%) | $42.84 M(-2.0%) |
| Jun 2021 | - | $31.50 M(>+9900.0%) | $43.71 M(+247.0%) |
| Mar 2021 | - | $0.00(-100.0%) | $12.60 M(-1.8%) |
| Dec 2020 | $12.83 M(>+9900.0%) | $11.34 M(+1197.7%) | $12.83 M(+764.3%) |
| Sep 2020 | - | $874.10 K(+130.0%) | $1.48 M(+143.3%) |
| Jun 2020 | - | $380.00 K(+65.2%) | $610.00 K(+165.2%) |
| Mar 2020 | - | $230.00 K | $230.00 K |
| Dec 2019 | $100.00 K | - | - |
FAQ
- What is Reviva Pharmaceuticals Holdings annual cash flow from financing activities?
- What is the all time high annual CFF for Reviva Pharmaceuticals Holdings?
- What is Reviva Pharmaceuticals Holdings annual CFF year-on-year change?
- What is Reviva Pharmaceuticals Holdings quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Reviva Pharmaceuticals Holdings?
- What is Reviva Pharmaceuticals Holdings quarterly CFF year-on-year change?
- What is Reviva Pharmaceuticals Holdings TTM cash flow from financing activities?
- What is the all time high TTM CFF for Reviva Pharmaceuticals Holdings?
- What is Reviva Pharmaceuticals Holdings TTM CFF year-on-year change?
What is Reviva Pharmaceuticals Holdings annual cash flow from financing activities?
The current annual CFF of RVPH is $33.17 M
What is the all time high annual CFF for Reviva Pharmaceuticals Holdings?
Reviva Pharmaceuticals Holdings all-time high annual cash flow from financing activities is $33.17 M
What is Reviva Pharmaceuticals Holdings annual CFF year-on-year change?
Over the past year, RVPH annual cash flow from financing activities has changed by +$25.38 M (+325.69%)
What is Reviva Pharmaceuticals Holdings quarterly cash flow from financing activities?
The current quarterly CFF of RVPH is $3.62 M
What is the all time high quarterly CFF for Reviva Pharmaceuticals Holdings?
Reviva Pharmaceuticals Holdings all-time high quarterly cash flow from financing activities is $31.50 M
What is Reviva Pharmaceuticals Holdings quarterly CFF year-on-year change?
Over the past year, RVPH quarterly cash flow from financing activities has changed by +$3.62 M (+100.00%)
What is Reviva Pharmaceuticals Holdings TTM cash flow from financing activities?
The current TTM CFF of RVPH is $33.91 M
What is the all time high TTM CFF for Reviva Pharmaceuticals Holdings?
Reviva Pharmaceuticals Holdings all-time high TTM cash flow from financing activities is $43.71 M
What is Reviva Pharmaceuticals Holdings TTM CFF year-on-year change?
Over the past year, RVPH TTM cash flow from financing activities has changed by +$27.99 M (+472.84%)